[1] |
Wright P. Filamentary keratitis. Trans Ophthalmol Soc U K,1975,95:260-266.
|
[2] |
陆琳娜,周丹虹,张志强. 准分子激光原位角膜磨镶术后丝状角膜病变原因分析. 眼视光学杂志,2006,8:146-147.
|
[3] |
Kinoshita S, Yokoi N. Filamentary keratitis//Foster CS, Azar DT, Dohlman CH, eds. Smolin and thoft′s the cornea: scientific foundations and clinical practice. 4th ed. Philadelphia: Lippincott Williams & Wilkins,2005:681-686.
|
[4] |
Davidson RS, Mannis MJ. Filamentary keratitis//Krachner JH, Mannis MJ, Holland EJ, eds. Cornea. 2nd ed. Philadelphia: Elsevier Mosby,2005:1179-1182.
|
[5] |
Albietz J, Sanfilippo P, Troutbeck R, et al. Management of filamentary keratitis associated with aqueous-deficient dry eye. Optom Vis Sci,2003,80:420-430.
|
[6] |
Diller R, Sant S. A case report and review of filamentary keratitis. Optometry,2005,76:30-36.
|
[7] |
Kakizaki H, Zako M, Mito H, et al. Filamentary keratitis improved by blepharoptosis surgery: two cases. Acta Ophthalmol Scand,2003,81:669-671.
|
[8] |
Hu Y, Matsumoto Y, Adan ES, et al. Corneal in vivo confocal scanning laser microscopy in patients with atopic keratoconjunctivitis. Ophthalmology,2008,115:2004-2012.
|
[9] |
Vaddavalli PK, Garg P, Sharma S, et al. Confocal microscopy for Nocardia keratitis. Ophthalmology,2006,113:1645-1650.
|
[10] |
Carlson EC, Drazba J, Yang X, et al. Visualization and characterization of inflammatory cell recruitment and migration through the corneal stroma in endotoxin-induced keratitis. Invest Ophthalmol Vis Sci,2006,47:241-248.
|
[11] |
Cheng LL, Young AL, Wong AK, et al. In vivo confocal microscopy of Thygeson′s superficial punctate keratitis. Clin Experiment Ophthalmol,2004,32:325-327.
|
[12] |
Kim TI, Roh MI, Grossniklaus HE, et al. Deposits of transforming growth factor-beta-induced protein in granular corneal dystrophy type II after LASIK. Cornea,2008,27:28-32.
|
[13] |
Ko MK, Kay EP. Differential interaction of molecular chaperones with procollagen I and type IV collagen in corneal endothelial cells. Mol Vis,2002,11:1-9.
|
[14] |
Adams AD. The morphology of human conjunctival mucus. Arch Ophthalmol,1979,97:730-734.
|
[15] |
Avisar R, Robinson A, Appel I, et al. Diclofenac sodium, 0.1% (Voltaren Ophtha), versus sodium chloride, 5%, in the treatment of filamentary keratitis. Cornea,2000,19:145-147.
|
[16] |
Tanioka H, Yokoi N, Komuro A, et al. Investigation of the corneal filament in filamentary keratitis. Invest Ophthalmol Vis Sci,2009,50:3696-702.
|
[17] |
Marsh P, Pflugfelder SC. Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sj?觟gren syndrome. Ophthalmology,1999,106:811-816.
|
[18] |
Grinbaum A, Yassur I, Avni I. The beneficial effect of diclofenac sodium in the treatment of filamentary keratitis. Arch Ophthalmol,2001,119:926-927.
|
[19] |
Urashima H, Okamoto T, Takeji Y, et al. Rebamipide increases the amount of mucin-like substances on the conjunctiva and cornea in the N-acetylcysteine-treated in vivo model. Cornea,2004,23:613-619.
|
[20] |
Rotkis WM, Chandler JW, Forstot SL. Filamentary keratitis following penetrating keratoplasty. Ophthalmology,1982,89:946-949.
|
[21] |
Niederer RL, Perumal D, Sherwin T, et al. Corneal innervation and cellular changes after corneal transplantation: an in vivo confocal microscopy study. Invest Ophthalmol Vis Sci,2007, 48:621-626.
|
[22] |
Berry M, Ellingham RB, Corfield AP. Human preocular mucins reflect changes in surface physiology. Br J Ophthalmol,2004, 88:377-383.
|